18F-Sodium Fluoride Positron Emission Tomography/Computed Tomography in Ex Vivo Human Coronary Arteries With Histological Correlation

Arterioscler Thromb Vasc Biol. 2020 Feb;40(2):404-411. doi: 10.1161/ATVBAHA.119.312737. Epub 2019 Dec 26.

Abstract

Objective: 18F-sodium fluoride (NaF) position emission tomography (PET) activity correlates with high-risk plaque. We examined the correlation between 18F-NaF PET activity and extent of calcification (microcalcification and macrocalcification) in coronary arteries. Approach and Results: Eighteen ex vivo human coronary arteries were imaged with 18F-NaF PET/CT, and target to background ratios were analyzed from 101 plaques. Histopathologic analysis evaluated for microcalcification and macrocalcification, plaque morphology, and inflammation. Plaques with microcalcification demonstrated higher 18F-NaF PET activity (n=84; mean target to background ratio±SD, 9.0±9.7,) than plaques without microcalcification (n=17, 2.9±3.8; P<0.0001). Higher 18F-NaF PET activity was associated with advanced plaques characterized by fibroatheroma (n=54, 10.7±10.3) compared with plaques with intimal thickening (n=22, 3.5±3.9) or pathological intimal thickening (n=25, 6.1±8.4; P=0.004). No significant association was found between 18F-NaF PET activity and inflammation (P=0.08).

Conclusions: In ex vivo human coronary arteries, higher 18F-NaF PET activity was associated with microcalcification and advanced plaque morphology. Since microcalcification and fibroatheromas are high-risk plaque features, 18F-NaF PET/CT may improve risk-stratification.

Keywords: atherosclerotic plaque; calcification; computed tomography angiography; inflammation; risk factor.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Coronary Artery Disease / diagnosis*
  • Coronary Vessels / diagnostic imaging*
  • Cross-Sectional Studies
  • Fluorodeoxyglucose F18 / pharmacology*
  • Follow-Up Studies
  • Humans
  • Immunohistochemistry
  • Positron Emission Tomography Computed Tomography / methods*
  • Prospective Studies
  • Radiopharmaceuticals / pharmacology
  • Vascular Calcification / diagnosis*

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18